AU2001276682A1 - Sugar absorption inhibitors and process for producing the same - Google Patents
Sugar absorption inhibitors and process for producing the sameInfo
- Publication number
- AU2001276682A1 AU2001276682A1 AU2001276682A AU7668201A AU2001276682A1 AU 2001276682 A1 AU2001276682 A1 AU 2001276682A1 AU 2001276682 A AU2001276682 A AU 2001276682A AU 7668201 A AU7668201 A AU 7668201A AU 2001276682 A1 AU2001276682 A1 AU 2001276682A1
- Authority
- AU
- Australia
- Prior art keywords
- evening primrose
- primrose seed
- aforementioned
- defatted
- absorption inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
- Fats And Perfumes (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
This invention provides carbohydrate absorption inhibitor derived from evening primrose seed which is significantly effective to prevent and cure diabetes mellitus and prevent obesity, and the manufacturing method of the same. Carbohydrate absorption inhibitor in this invention is characterized that the effective component is an alcohol extract of evening primrose seed. The aforementioned evening primrose seed is preferably a defatted evening primrose seed. Extracting solvent of the aforementioned evening primrose seed is preferably ethanol, or preferably a 70 to 85% (v/v) aqueous ethanol. Also, this invention is characterized that the carbohydrate absorption inhibitor is an effective component of polyphenol derived from evening primrose seed. The polyphenol is preferably one or more substances selected from among gallic acid, ellagic acid, catechin, pentagalloylglucose, procyanidin, and proantocyanidin. The manufacturing method of the carbohydrate absorption inhibitor in this invention is characterized to be composed of the following processes A to C. Process A: evening primrose is compressed, oil is separated then the compressed cake is obtained. Process B: The aforementioned compressed cake is defatted in fat-soluble organic solvent, and defatted substance is obtained. Process C: The aforementioned defatted substance is extracted by alcohol, and then this extracted liquid is concentrated or evaporated. <IMAGE>
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000232930 | 2000-08-01 | ||
JP2000-232930 | 2000-08-01 | ||
PCT/JP2001/006436 WO2002009734A1 (en) | 2000-08-01 | 2001-07-26 | Sugar absorption inhibitors and process for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001276682A1 true AU2001276682A1 (en) | 2002-02-13 |
Family
ID=18725531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001276682A Abandoned AU2001276682A1 (en) | 2000-08-01 | 2001-07-26 | Sugar absorption inhibitors and process for producing the same |
Country Status (8)
Country | Link |
---|---|
US (2) | US6932990B2 (en) |
EP (1) | EP1312374B1 (en) |
JP (1) | JP4873824B2 (en) |
CN (1) | CN1268351C (en) |
AT (1) | ATE407689T1 (en) |
AU (1) | AU2001276682A1 (en) |
DE (1) | DE60135760D1 (en) |
WO (1) | WO2002009734A1 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020035071A1 (en) * | 1997-07-08 | 2002-03-21 | Josef Pitha | Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites |
US8563522B2 (en) * | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
US7713546B1 (en) | 2001-04-03 | 2010-05-11 | Soft Gel Technologies, Inc. | Corosolic acid formulation and its application for weight-loss management and blood sugar balance |
US7666459B2 (en) | 2001-09-12 | 2010-02-23 | The Procter & Gamble Company | Pet food compositions |
KR20030075947A (en) * | 2002-03-19 | 2003-09-26 | 제네티카 주식회사 | Angiogenesis inhibitor |
EP1545554A4 (en) * | 2002-07-24 | 2006-06-14 | Univ Ohio | Methods and compositions for treating diabetes mellitis |
JP4541662B2 (en) * | 2003-05-29 | 2010-09-08 | オリザ油化株式会社 | Anti-pylori composition |
GB0321996D0 (en) * | 2003-09-19 | 2003-10-22 | Novartis Nutrition Ag | Organic compounds |
JP2006335758A (en) * | 2003-10-06 | 2006-12-14 | Oriza Yuka Kk | Composition for diet |
CN1863543B (en) * | 2003-10-06 | 2010-06-16 | 奥力榨油化株式会社 | Dietetic composition |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
EP1557094A1 (en) * | 2004-01-26 | 2005-07-27 | Wageningen Centre for Food Sciences | Improved semi-solid food products and methods for their production based on inhibiting amylase induced starch breakdown |
US20050251265A1 (en) * | 2004-05-07 | 2005-11-10 | Calandruccio James H | Trapezium implant for thumb and method |
US20050249837A1 (en) * | 2004-05-10 | 2005-11-10 | The Procter & Gamble Company | Processes for preparing plant matter extracts and pet food compositions |
US20090252834A1 (en) * | 2004-05-10 | 2009-10-08 | Michael Griffin Hayek | Compositions comprising glucose anti-metabolites |
CN101001539B (en) * | 2004-06-04 | 2012-05-30 | 视界科技有限公司 | Natural sweetener |
JP5020462B2 (en) * | 2004-06-16 | 2012-09-05 | クラシエフーズ株式会社 | α-Glucosidase inhibitor and food using the same |
JP2006016330A (en) * | 2004-06-30 | 2006-01-19 | Suntory Ltd | Fat-burning accelerating agent |
US20060051435A1 (en) * | 2004-08-19 | 2006-03-09 | Udell Ronald G | Nutritional supplement for body fat reduction |
JP2006056850A (en) * | 2004-08-23 | 2006-03-02 | Suntory Ltd | Lipase inhibitor |
EP1788390B1 (en) * | 2004-08-30 | 2010-04-14 | Takeda Pharmaceutical Company Limited | Screening method |
JP2006104181A (en) * | 2004-09-13 | 2006-04-20 | Takahiro Tsujita | Glucide-splitting enzyme-inhibiting material derived from fagaceae plant and application thereof |
CN100566723C (en) * | 2004-09-13 | 2009-12-09 | 辻田隆广 | Carbohydrase inhibitor and application thereof derived from the acorn-cup plant |
CA2609617C (en) | 2005-05-31 | 2014-07-08 | The Iams Company | Feline probiotic lactobacilli |
BRPI0611492B1 (en) | 2005-05-31 | 2021-10-13 | Mars, Incorporated | BIFIDOBACTERIA PROBIOTICS FELINE |
AU2006254652B2 (en) | 2005-06-03 | 2011-04-21 | Poly Gain Pte Ltd | Substances having body mass redistribution properties |
WO2007019526A2 (en) * | 2005-08-05 | 2007-02-15 | Naturegen, Inc. | Compositions and methods for controlling glucose and lipid uptake from foods |
KR100829083B1 (en) | 2006-07-28 | 2008-05-16 | 재단법인 제주하이테크산업진흥원 | Oenothera laciniata extracts having physiological activity |
AU2007299581B2 (en) * | 2006-09-19 | 2011-04-28 | Poly Gain Pte Ltd | Extracts derived from sugar cane and a process for their manufacture |
MX2009008165A (en) * | 2007-02-01 | 2009-08-12 | Iams Company | Method for decreasing inflammation and oxidative stress in mammals. |
JP5799299B2 (en) * | 2007-02-01 | 2015-10-21 | ザ・アイムス・カンパニーThe Iams Company | Method for reducing inflammation and stress in mammals using glucose antimetabolite, avocado or avocado extract |
WO2009137859A1 (en) | 2008-05-15 | 2009-11-19 | Alois Jungbauer | Compounds for the treatment of metabolic syndrome and insulin resistance |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
GB2475657B (en) * | 2008-08-22 | 2013-05-29 | Relypsa Inc | Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia |
CN102170890B (en) * | 2008-10-08 | 2013-03-20 | 百佳株式会社 | Anti-avian influenza virus agent, and product containing anti-avian influenza virus agent |
JP2010184909A (en) * | 2009-02-13 | 2010-08-26 | Rheology Kino Shokuhin Kenkyusho:Kk | Functional composition and pharmaceutical or health food comprising the composition |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
CN102018766B (en) | 2009-09-16 | 2013-03-06 | 博仲盛景医药技术(北京)有限公司 | Plant extractive, extraction method and application thereof as well as composite comprising same |
CA2860448C (en) | 2011-02-08 | 2019-09-10 | Horizon Science Pty Ltd | Molasses extract enriched in polyphenols and uses thereof |
RU2451506C1 (en) * | 2011-06-02 | 2012-05-27 | Сергей Юрьевич Лешков | Combination for treatment of diabetes and complications thereof |
CN104780987B (en) | 2012-08-28 | 2018-10-30 | 产品制造商(澳大利亚)有限公司 | extracting method |
JP2014198684A (en) * | 2013-03-29 | 2014-10-23 | サンスター株式会社 | Blood sugar metabolism improver |
CN105722520A (en) | 2013-08-16 | 2016-06-29 | 产品制造商(澳大利亚)有限公司 | Sugar cane derived extracts and methods of treatment |
JP6998108B2 (en) | 2016-03-07 | 2022-01-18 | 株式会社ダイセル | Α-Glucosidase activity inhibitor containing urolithins and blood glucose increase inhibitor containing urolithins |
CA3086827A1 (en) * | 2017-12-27 | 2019-07-04 | Suntory Holdings Limited | Composition for improving intestinal barrier function |
JPWO2022085602A1 (en) * | 2020-10-20 | 2022-04-28 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3018013B2 (en) * | 1989-10-19 | 2000-03-13 | 三井農林株式会社 | α-amylase activity inhibitor |
JPH09176019A (en) * | 1995-12-26 | 1997-07-08 | Suntory Ltd | Carbohydrate-degradative/digestive enzyme inhibitor and medicine and food/beverage formulated therewith |
PT815857E (en) | 1995-12-26 | 2005-01-31 | Suntory Ltd | ANTI-OBESITY AGENT PROCIANIDIN AS ACTIVE INGREDIENT |
AU9369198A (en) * | 1998-09-30 | 2000-04-17 | Industrial Research Limited | Antioxidant compositions and process for their preparation |
-
2001
- 2001-07-26 WO PCT/JP2001/006436 patent/WO2002009734A1/en active IP Right Grant
- 2001-07-26 US US10/343,488 patent/US6932990B2/en not_active Expired - Fee Related
- 2001-07-26 DE DE60135760T patent/DE60135760D1/en not_active Expired - Lifetime
- 2001-07-26 JP JP2002515287A patent/JP4873824B2/en not_active Expired - Lifetime
- 2001-07-26 CN CNB01816661XA patent/CN1268351C/en not_active Expired - Fee Related
- 2001-07-26 EP EP01954345A patent/EP1312374B1/en not_active Expired - Lifetime
- 2001-07-26 AT AT01954345T patent/ATE407689T1/en not_active IP Right Cessation
- 2001-07-26 AU AU2001276682A patent/AU2001276682A1/en not_active Abandoned
-
2004
- 2004-03-19 US US10/803,873 patent/US20060024396A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1312374A4 (en) | 2004-04-21 |
EP1312374B1 (en) | 2008-09-10 |
JP4873824B2 (en) | 2012-02-08 |
CN1268351C (en) | 2006-08-09 |
WO2002009734A8 (en) | 2002-02-28 |
EP1312374A1 (en) | 2003-05-21 |
ATE407689T1 (en) | 2008-09-15 |
US20060024396A1 (en) | 2006-02-02 |
DE60135760D1 (en) | 2008-10-23 |
US20030161903A1 (en) | 2003-08-28 |
CN1468106A (en) | 2004-01-14 |
WO2002009734A1 (en) | 2002-02-07 |
US6932990B2 (en) | 2005-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001276682A1 (en) | Sugar absorption inhibitors and process for producing the same | |
CN101113133B (en) | Method for extracting carnosic acid | |
KR102415857B1 (en) | Methods for Extracting, Processing, and Purifying Selected Families of Target Compounds from Cannabis | |
Ferreira et al. | Antinociceptive effect from Ipomoea cairica extract | |
CA2633571A1 (en) | Recovery of residual plant components after distillation of essential oils | |
Pacifico et al. | Neuroprotective potential of Laurus nobilis antioxidant polyphenol-enriched leaf extracts | |
Cecchi et al. | In depth study of phenolic profile and PTP-1B inhibitory power of cold-pressed grape seed oils of different varieties | |
WO2003061563A3 (en) | Method of preparing delta-9 tetrahydrocannabinol | |
WO2007080514A3 (en) | A method for the extraction of lipid fractions from krill | |
Kraujalienė et al. | Biorefining of Bergenia crassifolia L. roots and leaves by high pressure extraction methods and evaluation of antioxidant properties and main phytochemicals in extracts and plant material | |
Foddai et al. | In vitro inhibitory effects of Sardinian Pistacia lentiscus L. and Pistacia terebinthus L. on metabolic enzymes: Pancreatic lipase, α‐amylase, and α‐glucosidase | |
KR960003739A (en) | Method for preparing plant active ingredient concentrates of low pesticide content | |
KR20010052636A (en) | Extracts of Hypericum perforatum and formulations containing them | |
RU2514673C2 (en) | Method of removing pesticides from ginkgo biloba extracts and extracts obtained using said method | |
JP5212687B2 (en) | Method for quantifying compound having α-glucosidase inhibitory activity, and method for evaluating α-glucosidase inhibitory activity of Sarachia plant or extract thereof | |
Schmeda-Hirschmann et al. | Male sexual enhancers from the Peruvian Amazon | |
JP7038992B2 (en) | How to identify licorice plant species | |
Hashim et al. | Antioxidant and α-glucosidase inhibitory constituents from Hornstedtia species of Malaysia | |
Raduan et al. | Antioxidant capabilities of Litsea garciae bark extracts and their relation to the phytochemical compositions | |
WO2009024317A1 (en) | Method of making distilled olive juice extracts | |
EP3922633A1 (en) | Method for extracting pyrrolizidine alkaloids | |
Yuliet et al. | Inhibitory Activity Of The Active Compound Of Ethyl Acetate Fraction Of Tamoenju (Hibiscus Surattensis L.) Leaves Against Α-Glucosidase And Dipeptidyl Peptidase-4 Enzymes | |
US20220125869A1 (en) | Method for obtaining oleocanthal type secoiridoids and for producing respective pharmaceutical preparations | |
WO2020090813A1 (en) | Method for producing flavonoid | |
Grauzdytė | Phytochemical composition and in vitro bioactivity of low investigated Phyllanthus phillyreifolius and Aphloia theiformis plant species indigenous to Reunion Island |